InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by Meek David D., Director. Officer active across 3 companies, notably Mirati Therapeutics, Inc.. In total, 7 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €9k. History available since 14 January 2022. The latest transaction was filed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
9,080 shares0Ordinary SharesSEC:0000904454-22-000352:0
602 shares@ US$16.700.0006% mcap100.0% of flowOrdinary SharesSEC:0000904454-22-000215:0
1,534 shares0Ordinary SharesSEC:0000904454-22-000193:0
27,500 shares0Common StockSEC:0001104659-22-005415:0
27,500 shares0Common StockSEC:0001104659-22-005415
34,057 shares0Common StockSEC:0001214659-22-000844
34,057 shares0Common StockSEC:0001214659-22-000844:0
7 of 7 declarations
About Meek David D.
David D. Meek is Chief Executive Officer and Director at Mirati Therapeutics, Inc., Entasis Therapeutics Holdings Inc., and uniQure N.V. He leads these companies in developing innovative therapies for serious diseases. David uses his expertise to guide the strategy and growth of these organizations.
